Time
|
Speaker
|
Topic
|
|
08:55
|
Panos Macheras
Department of Pharmacy, National & Kapodistrian Univeristy of Athens
|
Welcome – Introduction
|
|
09:00
|
Panos Macheras
Department of Pharmacy, National & Kapodistrian Univeristy of Athens
|
The false assumption that breaks pharmacokinetics of oral drug absorption.
|
|
09:30
|
Panos Macheras
Department of Pharmacy, National & Kapodistrian Univeristy of Athens
|
The rise of physiologically based finite time pharmacokinetic (PBFTPK) models
|
|
10:30
|
Coffee Break
|
||
11:00
|
Pavlos Chrysafidis
Department of Pharmacy, National & Kapodistrian Univeristy of Athens
|
Analysis of pharmacokinetic data using the PBFTPK software
|
|
11.30
|
Panos Macheras
Department of Pharmacy, National & Kapodistrian Univeristy of Athens
|
Implications of finite absorption time on Bioavailability and Bioequivalence
|
|
12.00
|
Light lunch
|
||
13.00
|
Nikos ALimbertis
Department of Pharmacy, National & Kapodistrian Univeristy of Athens
|
Analysis of bioequivalence data using the finite absorption time (FAT) concept
|
|
13.30
|
Rebeka Jereb
Sandoz development center, Ljubljana, Slovenia
|
Evaluating the impact of gastrointestinal tract properties on drug in vivo performance using PBPK modeling and virtual clinical trials
|
|
14.00
|
Sandra Cvijic
Department of Pharmaceuitcal Technology, University of Belgrade
|
Tackling the challenges of PBPK modeling for inhaled drugs
|
|
14:30
|
Coffee Break
|
|
|
15:00
|
Iztok Grabnar
Faculty of Pharmacy, University of Ljubljana
|
Modeling complex absorption in a population analysis using empirical functions
|
|
15:30
|
Ioannis Loisios Konstantinidis
Novartis, Basel, Switzerland
|
PBPK-IVIVE linked models to inform virtual bioequivalence trials
|
|
16:00
|
Filippos Kesisoglou
Merck & Co., Inc., Rahway, NJ, USA
|
Can PBPK Modeling Streamline Food Effect Assessments?
|
|
16:30
|
Wrap-up & end of workshop
|
|